ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,939Medicare Part D Prescriptions Filled, Including Refills

Rank: 299 out of 1456

$604K Total Retail Price of All Prescriptions

Rank: 338 out of 1456

429 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 429 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

11% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,953 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 594 500 1 1
LEVOTHYROXINE SODIUM 406 349 2 4
SIMVASTATIN 342 300 3 2
LISINOPRIL 327 243 4 3
FUROSEMIDE 305 284 5 7
PRAVASTATIN SODIUM 305 249 5 9
HYDROCHLOROTHIAZIDE 287 254 7 10
ATORVASTATIN CALCIUM 279 211 8 11
METOPROLOL TARTRATE 210 184 9 12
POTASSIUM CHLORIDE 209 176 10 15
HYDROCODONE-ACETAMINOPHEN 206 172 S3 11 6
DIOVAN 192 177 12 35
OMEPRAZOLE 186 149 13 5
METFORMIN HCL 179 123 14 8
WARFARIN SODIUM 178 146 15 21
TRAMADOL HCL 178 124 15 17
CITALOPRAM HBR 155 145 17 22
ZOLPIDEM TARTRATE 152 120 18 14
METOPROLOL SUCCINATE 151 135 19 19
CARVEDILOL 143 105 20 20
RANITIDINE HCL 138 133 21 27
DONEPEZIL HCL 131 131 22 29
GABAPENTIN 128 100 23 13
TAMSULOSIN HCL 127 127 24 34
LOSARTAN POTASSIUM 124 120 25 16
FAMOTIDINE 112 82 26 45
ATENOLOL 110 89 27 18
MIRTAZAPINE 105 92 28 65
CRESTOR 105 70 28 26
PREDNISONE 97 88 30 42
LOVASTATIN 96 89 31 40
FLUOXETINE HCL 94 71 32 55
QUETIAPINE FUMARATE 85 59 33 78
NAMENDA 83 81 34 38
NEXIUM 82 79 35 23
PANTOPRAZOLE SODIUM 80 69 36 43
CLONIDINE HCL 77 67 37 39
ALLOPURINOL 75 49 38 31
DIOVAN HCT 74 62 39 59
NOVOLIN 70-30 74 62 39 144
CIPROFLOXACIN HCL 73 61 41 58
LOSARTAN-HYDROCHLOROTHIAZIDE 71 58 42 41
FLUTICASONE PROPIONATE 70 67 43 28
FELODIPINE ER 62 51 44 150
AZITHROMYCIN 60 53 45 44
CELEBREX 60 59 45 88
SPIRONOLACTONE 58 57 47 73
JANUVIA 57 36 48 68
CLOPIDOGREL 56 54 49 32
ALENDRONATE SODIUM 55 46 50 36
TRIAMTERENE-HCTZ 54 34 51 49
FENOFIBRATE 54 35 51 56
LIPITOR 54 31 51 76
TRAMADOL HCL-ACETAMINOPHEN 53 53 54 139
ESCITALOPRAM OXALATE 53 44 54 74
KLOR-CON M20 51 38 56 51
FENTANYL 51 51 S2 56 114
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 34 58 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.